BPA Call HHSI239200710514B-HHSI2397010051406

This is a $577,405.70 firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer and supplier. The contract is for the provision of reagents and consumable supplies, with a period of performance ending on September 30, 2021. No set-aside designation was used for this award. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that specializes in...

This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Ortho-Clinical Diagnostics Inc. The $106,044.52 contract is for the purchase of multiple reagent products to be used with the vendor's ProVue analyzer. This appears to be a recurring cost-per-test contract, as the description indicates the purchase of reagents for the vendor-owned analyzer. No set-aside designation was used. Ortho-Clinical Diagnostics Inc. is a for-profit...

Ortho-Clinical Diagnostics, Inc. was awarded a $1,156.61 fixed-price delivery order by the Defense Medical Supply Chain on July 14, 2025, for the supply of Anti-A Bioclone 15x10ml reagent products. The contract is scheduled for ultimate completion by August 4, 2025, and will be performed at the company's facility in Raritan, New Jersey. No small business set-aside designation was utilized for this award, indicating open competition among qualified vendors. This delivery order represents a...

Ortho-Clinical Diagnostics Inc. was awarded a $43,040 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide approximately 10 ml of anti-IgG reagent to the agency over a three-day period of performance in August 2023. The firm fixed price order was awarded to Ortho-Clinical Diagnostics Inc. for supply of the specified medical reagent to support the Defense Logistics Agency Troop Support...

This firm fixed price delivery order was awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. for $1,016,444.96 to provide chemistry analyzers, reagents, supplies, training, and maintenance support. The award does not include a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturer that has provided a range of diagnostic solutions and laboratory equipment to various federal agencies, including the Department of Veterans Affairs, Department...

This contract was awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, on November 16, 2018. The $176,918.01 firm fixed price delivery order is for in vitro diagnostic reagents and test kits. No set-aside was used. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including blood bank analyzers, chemistry analyzers, reagents, and test kits, to federal agencies such as the Department of Veterans...

The Department of Veterans Affairs Veterans Health Administration awarded a $159,060.92 firm-fixed price delivery order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, for the provision of reagents. The contract is associated with the Critical Analyzers, Laboratory (FSS-66-III) federal supply schedule and is being performed in Raritan, New Jersey. Ortho-Clinical Diagnostics has provided a wide range of diagnostic solutions, including analyzers, reagents,...

This is a firm fixed-price purchase order awarded by the Air Combat Command, a defense agency, to Ortho-Clinical Diagnostics, Inc. for reagents. The contract has a ceiling value of $132,057.59 and an ultimate completion date of September 29, 2020. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturing company that has provided various diagnostic solutions, equipment, reagents, and services to multiple federal agencies. This award does not have a set-aside designation....

Ortho-Clinical Diagnostics Inc. was awarded a $201,879.93 delivery order against the Critical Analyzers, Laboratory (FSS-66-III) schedule contract to provide various orthopedic-clinical diagnostics reagents to the Defense Health Agency. The delivery order has a completion date of September 30, 2024 and was awarded on October 1, 2021 under a firm fixed price contracting method. Performance will take place in Raritan, New Jersey. Ortho-Clinical Diagnostics Inc. is a medical equipment...

Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...